Erhan Gokmen

Izmir, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Silica-boron composite nanoparticles: from architecture to mechanical performance.

Silica-boron composite nanoparticles: from architecture to mechanical performance.

Journal: RSC advances

Published: May 20, 2026

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study.

Real-world associations of pathological complete response and survival with neoadjuvant pembrolizumab in early TNBC: a Turkish Oncology Group study.

Journal: Scientific reports

Published: January 09, 2026

Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.

Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.

Journal: Frontiers in oncology

Published: November 28, 2025

Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study.

Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study.

Journal: BMJ supportive & palliative care

Published: November 14, 2025

Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.

Endocrine Therapy versus Chemotherapy After CDK4/6 Inhibitor Progression in HR+/HER2- Metastatic Breast Cancer: A Multicenter Real-World Study from Turkey.

Journal: Breast cancer (Dove Medical Press)

Published: September 30, 2025

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety.

Journal: Current oncology (Toronto, Ont.)

Published: September 27, 2025

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Efficacy of Subsequent Therapy in Patients with Hormone-Positive Advanced Breast Cancer with Disease Progression After CDK4/6 Inhibitor Therapy: Multicenter Real-Life Data.

Journal: Journal of clinical medicine

Published: September 09, 2025

DUSP29 does not regulate melanoma-myoblast interactions in a skeletal muscle co-culture model.

DUSP29 does not regulate melanoma-myoblast interactions in a skeletal muscle co-culture model.

Journal: Scientific reports

Published: August 31, 2025

Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis.

Real-World Outcomes of Adjuvant Paclitaxel and Trastuzumab Therapy in Lymph Node-Negative, HER2-Positive Early-Stage Breast Cancer: A Multicenter Retrospective Data Analysis.

Journal: Cancers

Published: June 17, 2025

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Real-world comparison of cabozantinib and sunitinib in advanced non-clear cell renal cell carcinoma: A multicenter study by the Turkish Oncology Group.

Journal: International journal of cancer

Published: May 16, 2025

Malignant transformations in mature cystic teratomas: A case report and literature review.

Malignant transformations in mature cystic teratomas: A case report and literature review.

Journal: Medicine international

Published: April 11, 2025

Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut-Offs.

Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long-Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut-Offs.

Journal: World journal of surgery

Published: April 06, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026